Phân tầng nguy cơ trong bệnh cơ tim phì đại

Phan tang 0U t trong

bent co'tim phi da

15.85, Trén Vi Minh Thy

Bệnh tiện da koTaam Anh

HOV NGH SIU AM TOAN QUOC LAN TH sku VSUM. /
THEA NATO CONGRESS OF VETNANESE SOCEY OF WUTRASOLND N HEDINE

Tinh phd Hub gy O10 thi09nnm 4] Hun Cy, March 009, a4 ""I HM

Mo dau

Tansuat 1500 i/

+ Phi dai don dc co'tim, chi yeu

lady tht tr, : a

"Khong [a hau qua cua cdc bénh

lệ thống, lận tin lay lệnh

chuydaenae

+ Be dy vach tim cudi tm rac > 15 mm bat ci vit ndo

cla tht ta

+ Be dy ti 13-14 mm trén ng cd mang gene BCTPD hose

nguci cd bénh st gia din co BCTPD /

tlna Abela etl (203), European Heart Jornal, 0, 1-124 a4 i \

Jin lên tỊ hiên

$y lên lim

ER

cud

Lénh tinh

On inh
(Tuitho

Binh

Spinto etal. N Engl Med, 10733971245 thudng)

Lên quan gif bénh co tim ph dal va dott

Hii (340) th in thudug 04)

bea ken ion (34)
Vi dong mach ci (24)

sarcoidosis (1%)

bea co tim din nd (24)
hep ding nyc ch)

MaroBnl, Doerr JJ, Maas TS etl 2006)‘S,udden deahs in young competitive ahees (/

Roiloan ni Kich boat may phé rung cy doc

Nhio nhanh thatva rung that
MpHzMM Apart
varung th

/

Rung tha

Maron Bd, Shen IK, Link MS et l(200), fica of implantable cardioverter defitiators forthe \ÑM/

prevention of sudden deat inpatients wth hypertrophic cardomyopaty’ | Enf la, 30, 383313 h \y

Ss=Hieu qua cla ICD trong phiong nga dott

Phong ngira thu phat

Ty lé tich I Gy sSc Gién £ ian đầu (%6) =

S=s

= =

S s

2 = Phòng ngừa tiên phat

Ss~

=

0 2 4 6 8 10 1 14

(CD: may ph ung cay dune Nắm đặt mát phá rung tất được \SUM /

Maron BJ, Shen WK, Link MS etl (200), “Eficacy ofimplantable crave. deflator forthe adi: (

preventionof sudden death inpatients with hypertrophic cardomyopathy”’. Engl Med, $42, $06

2023 ESC Cardiomyopathy Guidelines

High

Moderate

MTC TONG
' Tầnngafth nuuờifttử "Ti
"Nt aE ED CTA

OMA sco CNN

Dy TAU a Don

Л:01/1)0)2711010)000)110)00)

OTN

GershB etal (2011),‘ACCH/AHA Guideline forthe Diagnoss and Treatmentof Hypertrophic Cardiomyopathy: a report

ofthe American College of Cardiology Foundation/Amercan Heart Association Task Frce on Practice Guidelines’,
Circultion, 124:2761-2796,

Ello PM etl (2044), "2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task

Foe a he Dag Magen pt Cardiomyopathy ofthe European Society of Cardiology \Ñ
(ESC)’ European fturl luimil (ti) flauhtaflhÚM

Twong quan gia sing ob va

yeu tO nguy co Gt tong BCTPE

100

Khong c6 yentguy co

4

© mnt yeu tO ny co

baytOengnuy co
hai yeyueuttoo nguy co
: n-4

ị wo

30+

40+

Log rank for trend p = 0.0922 bon yeu tO nguy co

a 3 4 5 67 T7

0 12 Theo di xin) 8 90

Eliot PM etal. Left ventricular outfltorawct obstruction and sudden deat isk inpatienwtsh

Chi din dat CD theo AHA

Tien cannguntgin! . Nen dat CD

ANNUaN

(lữ

TCIMTNL oh | Cothé yem xb dat CD

SOMERS

Fee MUG CG

Ihiphanh ti thôn kế tài > Yom yet yeu tb nguy oo kde

Pee d —

| kon J hi Co the xem xt 10D

AIRE) | CD hg che hn

Getsh Bet al, 2011 “ACCF/AHA Guideline forthe Diagnoss and Treatment of Hypertrophic

Mohinh tinh nquy co’ dot

HOM Risk-SCD Calculator

Age - Yạun M009 v

EUROPEAN MĐÍNULVAÍ mm - P00000f26006/0/)000060006 TH [U(UÍU

90(TYOF Wao mg lM0đ60u0@@@0wa6gi06@2i060666g0yMB

CARDIOLOGY® UWWMMM, porate ng apntneeo eavalua

Wax LVOT ng Thru uo ret mn too wh Nad v
d0 Jwovocoon (respecte of concen medal 94A0 080) 0/8600
‘ontrius wave Capper rom the apie! Pree and fv chamber views.
Faby oy Peo uto acl de shuld emned uy be ned
Eero qt Grae 4, whete prk ear sutr
‘veal 0
Yes sty cnn a7 ae gt ais an!
yer gr SCO na fa ye rt win ted HC at any
{ge (oso aiesnaiem agro).

consecutive ventcwiar beats a a rate of 120 deate por minute and «08
(rato on ae monary (menu Ouran 24 ours) ato ra
0/001

tof planed nope rio eatin

htto/wwm.doc2do.com/hem/webhhCtMml

Nquy co’ dt it theo nom

Nguy co dét ti & thoi adiém 5 nam -+1
+

o s+

o

0-24 2-4 4-01 6

Nhdm nguy co

Dy don MR Quan sat

(Mahony ¢, hi Pavlou M, etal (2014), ‘A novel clinical rik prediction model for sudden cardiac

OTTO nS eel

a
Dene retina ut Nt

0 /())001I01U 0N)
EEE U TALIA

1000200020001

tắn gýH0lIRI9-00

Lên “ Nuy co rung binh

tắm >i. Adi

hKhgôn nén dat 0) Cothvéem xét gat ICD | | Nén d@t ICD

Eliott PM, Anastasakis Borger MA et l(2014), EuroHpearet Jaounnal dost0,1093/eurhear/ehu 284,

ESC Congre2s0s17

Phong nqla dott ên phat o

bệnh nhân lệnh cơ tim phì đại (HCM-EVIDENCE)

2908/2017
Dr. Mahony etal

3703 bn ti Bac MY, Chu Au, Tung Bong, Chau A

Dung md hinh tinh nquy oo d6t ty BCTPD ESC

Kétludn

Cit mai 13 bénh nh nquy oo cao duoc dt ICD, ctusing

duoc1 bénh nhén kno dot

European Society of Cardiology

Đính á đột l) mơ hình nquy co dt ty

I(TP0tiaES

+ (629 nh nbn BCTPD tuoi 46 den
+ 40/199d2én 06/2014

* Tai 2trung tm BCTPD cla Vien Tim Minneapolis va Tut

Maron BJ, Casey SA, Garberch RF, et (2015), “Independent assessment ofthe European Sociely of
Cardiology sudden death risk model for hypertrophic cardiomyopathy’ Am J Cardiol, 116:757~764

0 0H Dt le (n=4()11:%) 06

rtề ee ee noe | dé sd nguy o cao. Hau
Ệ
h ht kinti gdin CD
9 0
H Nguy co cao KD sử:
¢
tị fung/nthhata(nn=h46)
£
Sts cmsb guy co

H
LÍ Rey i
a
abe nt)
#

I xe rl ten Nên cot

wWŒằww n) nu

BAN TT HN (1-9674% n4guy)co

thap; 8,7" vita 45% cao

Maron BJ, Casey SA, Garberch RF, etl (2015), ‘Independent assessment ofthe European Socey of
Cardiology sudden death risk model for hypertrophic cardiomyopathy’, Am J Cardiol, 116:757-764

Risk Stratification for Sudden Death in HOM

But, how low is
“Low Risk”?

No risk factors He

Incidence of Sudden Death in 653 HCM Patients

with Benign Clinical Presentation and without Risk Factors

(Median follow-up: 5.3 years)

death

o s

of sudden

o s

incidence Cumulative risk of sudden death at 10 years; 6.9%
({ sudden death/year every 180 patients)
o 2

Cumulative2 +

o o

“TTPEE=E==...-

0 § 1 1

Time from first evaluation (years)

Spirito et al, AJC 2014

Incidence of Sudden Death in 653 HCM Patients
with Benign Clinical Presentation and without Risk Factors

(Median follow-up: 5.3 years)

o«<

Cumulative incidence of sudden death
o s

o z At tho timo of sudden death, each of these patients had no

or mild symptoms and the majority were younger than 40 yrs

o.7 .- T9â2 S9đâđ

I § 1 1

Timo from first evaluation (years)

Splrto etal, ANC 2014

IItidente 0ƒ R(Ìlrelafed Death ln 033 Patlentfs with HCMCumulative incidence of HCM -related death`
=
and without Established Risk Markers

0S 4

Sudden death ——

| HF orstroke-elated death = = = =

=
=

Risk of death at 10 years;
Sudden death = 6.9%

HF or stroko-olated death 1.7% |

= „ T T T T
=

I 5 lš 1) 1

Followup (yts) \